Beam Therapeutics (BEAM) announced the appointment of Chirfi Guindo, chief marketing officer of Human Health at Merck & Co (MRK)., to its board of directors. Guindo is a seasoned executive in the pharmaceutical industry and has been a key leader at Merck for more than 25 years, where he held senior executive roles spanning global strategy, commercial operations and leadership in healthcare solutions.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- Beam Therapeutics management to meet virtually with Cantor Fitzgerald
- Beam Therapeutics participates in a conference call with JPMorgan
- Beam Therapeutics upgraded to Outperform from Market Perform at Leerink
- Beam Therapeutics Reports Steady Progress in Q3 2024
- Cathie Wood’s ARK Investment buys 162.5K shares of Beam Therapeutics today